Ajay Goel, PhD
City of Hope Medical Center
24
24
9
N/A
0
4
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+21 more interventions
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (20)
Showing 10 of 20 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Saleh K Saleh, MD
Minia University
Shared therapeutic areas:
Lin Shen, MD
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Tim F Greten, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Zhenfeng Zhang, MD, PhD
Second Affiliated Hospital of Guangzhou Medical University
Shared therapeutic areas:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Jeong Min Lee, MD
Seoul National University Hospital
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (24)
Showing 20 of 24 trials
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA
An Exosomal microRNA Signature for Preoperative Staging in Colon Cancer
Integrated Cf-miRNA and Exosomal miRNA Signature for Early Detection of Esophageal Squamous Cell Carcinoma
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer
Liquid Biopsy Using Exosomal miRNA Enables Risk Stratification of Potential Metastasis in Patients With Intrahepatic Cholangiocarcinoma.
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Forecasting Occult liveR Metastasis Using an Exosomal Signature for Intelligent Guided Hepatic Targeting
cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer
Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
Epigenetic Signature for CRC Early Detection
An Exosomal miRNA-based Liquid Biopsy for ICC Detection
Splicing-based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer
Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
Early-Onset Colorectal Cancer Recurrence
Early Onset Colorectal Cancer Detection
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
Detecting Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma (LyMIC)
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer
Stage II/III Colorectal Cancer Recurrence